Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Mar;95(3):472–478. doi: 10.1111/j.1365-2249.1994.tb07021.x

H-2b restriction of the immune response to the p126 Plasmodium falciparum antigen.

D M Banic 1, P Delplace 1, C Mazingue 1, D Camus 1
PMCID: PMC1535090  PMID: 8137542

Abstract

Inbred BALB/c (H-2d), CBA (H-2k) and C57B1/6 (H-2b) mice immunized with Plasmodium falciparum schizonts or culture supernates develop antibodies of different antigenic specificities. It has been observed that C57B1/6 mice were unable to produce detectable antibodies against the p126 antigen (native molecule and p73 or p50 processed fragments) compared with other inbred mice. Similar results were obtained using BALB congenic mice with a lack of p126 antibody response in H-2b mice, while H-2d and H-2k mice produced antibodies against the p126. Lymphocyte proliferation assays performed by incubation of spleen cells with immunopurified p126 were positive for immunized BALB/c (H-2d) and congenic H-2d or H-2k mice. On the other hand, no lymphocyte stimulation was observed with either C57B1/6 (H-2b) or congenic H-2b mice. These results suggest an MHC restriction of the immune response against the entire p126 (found in schizonts) and its p73 and p50 naturally processed fragments (found in culture supernates).

Full text

PDF
472

Images in this article

473Fig. 1
on p.473
474Fig. 2
on p.474
474Fig. 3
on p.474
475Fig. 4
on p.475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adorini L., Appella E., Doria G., Nagy Z. A. Mechanisms influencing the immunodominance of T cell determinants. J Exp Med. 1988 Dec 1;168(6):2091–2104. doi: 10.1084/jem.168.6.2091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adorini L., Sette A., Buus S., Grey H. M., Darsley M., Lehmann P. V., Doria G., Nagy Z. A., Appella E. Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5181–5185. doi: 10.1073/pnas.85.14.5181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banyal H. S., Inselburg J. Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies. Am J Trop Med Hyg. 1985 Nov;34(6):1055–1064. doi: 10.4269/ajtmh.1985.34.1055. [DOI] [PubMed] [Google Scholar]
  4. Bhatia A., Delplace P., Fortier B., Dubremetz J. F., Vernes A. Immunochemical analysis of a major antigen of Plasmodium falciparum (P126) among ten geographic isolates. Am J Trop Med Hyg. 1987 Jan;36(1):15–19. doi: 10.4269/ajtmh.1987.36.15. [DOI] [PubMed] [Google Scholar]
  5. Bzik D. J., Li W. B., Horii T., Inselburg J. Amino acid sequence of the serine-repeat antigen (SERA) of Plasmodium falciparum determined from cloned cDNA. Mol Biochem Parasitol. 1988 Sep;30(3):279–288. doi: 10.1016/0166-6851(88)90097-7. [DOI] [PubMed] [Google Scholar]
  6. Chulay J. D., Lyon J. A., Haynes J. D., Meierovics A. I., Atkinson C. T., Aikawa M. Monoclonal antibody characterization of Plasmodium falciparum antigens in immune complexes formed when schizonts rupture in the presence of immune serum. J Immunol. 1987 Oct 15;139(8):2768–2774. [PubMed] [Google Scholar]
  7. Coppel R. L., Crewther P. E., Culvenor J. G., Perrin L. H., Brown G. V., Kemp D. J., Anders R. F. Variation in p126, a parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biol Med. 1988 Dec;5(3):155–166. [PubMed] [Google Scholar]
  8. Debrabant A., Delplace P. Leupeptin alters the proteolytic processing of P126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1989 Mar 1;33(2):151–158. doi: 10.1016/0166-6851(89)90029-7. [DOI] [PubMed] [Google Scholar]
  9. Debrabant A., Maes P., Delplace P., Dubremetz J. F., Tartar A., Camus D. Intramolecular mapping of Plasmodium falciparum P126 proteolytic fragments by N-terminal amino acid sequencing. Mol Biochem Parasitol. 1992 Jul;53(1-2):89–95. doi: 10.1016/0166-6851(92)90010-h. [DOI] [PubMed] [Google Scholar]
  10. Del Giudice G., Cooper J. A., Merino J., Verdini A. S., Pessi A., Togna A. R., Engers H. D., Corradin G., Lambert P. H. The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines. J Immunol. 1986 Nov 1;137(9):2952–2955. [PubMed] [Google Scholar]
  11. Delplace P., Bhatia A., Cagnard M., Camus D., Colombet G., Debrabant A., Dubremetz J. F., Dubreuil N., Prensier G., Fortier B. Protein p126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites. Biol Cell. 1988;64(2):215–221. doi: 10.1016/0248-4900(88)90080-9. [DOI] [PubMed] [Google Scholar]
  12. Delplace P., Dubremetz J. F., Fortier B., Vernes A. A 50 kilodalton exoantigen specific to the merozoite release-reinvasion stage of Plasmodium falciparum. Mol Biochem Parasitol. 1985 Nov;17(2):239–251. doi: 10.1016/0166-6851(85)90021-0. [DOI] [PubMed] [Google Scholar]
  13. Delplace P., Fortier B., Tronchin G., Dubremetz J. F., Vernes A. Localization, biosynthesis, processing and isolation of a major 126 kDa antigen of the parasitophorous vacuole of Plasmodium falciparum. Mol Biochem Parasitol. 1987 Apr;23(3):193–201. doi: 10.1016/0166-6851(87)90026-0. [DOI] [PubMed] [Google Scholar]
  14. Enders B., Hundt E., Knapp B. Strategies for the development of an antimalarial vaccine. Vaccine. 1992;10(13):920–927. doi: 10.1016/0264-410x(92)90326-f. [DOI] [PubMed] [Google Scholar]
  15. Ferreira-da-Cruz M. de F., Machado-Passo R., Fortier B., Daniel-Ribeiro C. Development of an immunoenzymatic assay using a monoclonal antibody against a 50-kDa catabolite from the P126 Plasmodium falciparum protein to the diagnosis of malaria infection. Mem Inst Oswaldo Cruz. 1992;87 (Suppl 3):187–192. doi: 10.1590/s0074-02761992000700031. [DOI] [PubMed] [Google Scholar]
  16. Fortier B., Delplace P., Dubremetz J. F., Ajana F., Vernes A. Enzyme immunoassay for detection of antigen in acute Plasmodium falciparum malaria. Eur J Clin Microbiol. 1987 Oct;6(5):596–598. doi: 10.1007/BF02014260. [DOI] [PubMed] [Google Scholar]
  17. Good M. F., Berzofsky J. A., Maloy W. L., Hayashi Y., Fujii N., Hockmeyer W. T., Miller L. H. Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med. 1986 Aug 1;164(2):655–660. doi: 10.1084/jem.164.2.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Good M. F., Pombo D., Quakyi I. A., Riley E. M., Houghten R. A., Menon A., Alling D. W., Berzofsky J. A., Miller L. H. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1199–1203. doi: 10.1073/pnas.85.4.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Guillet J. G., Lai M. Z., Briner T. J., Buus S., Sette A., Grey H. M., Smith J. A., Gefter M. L. Immunological self, nonself discrimination. Science. 1987 Feb 20;235(4791):865–870. doi: 10.1126/science.2433769. [DOI] [PubMed] [Google Scholar]
  20. Hill A. V., Allsopp C. E., Kwiatkowski D., Anstey N. M., Twumasi P., Rowe P. A., Bennett S., Brewster D., McMichael A. J., Greenwood B. M. Common west African HLA antigens are associated with protection from severe malaria. Nature. 1991 Aug 15;352(6336):595–600. doi: 10.1038/352595a0. [DOI] [PubMed] [Google Scholar]
  21. Inselburg J., Bzik D. J., Li W. B., Green K. M., Kansopon J., Hahm B. K., Bathurst I. C., Barr P. J., Rossan R. N. Protective immunity induced in Aotus monkeys by recombinant SERA proteins of Plasmodium falciparum. Infect Immun. 1991 Apr;59(4):1247–1250. doi: 10.1128/iai.59.4.1247-1250.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Knapp B., Hundt E., Enders B., Küpper H. A. Protection of Aotus monkeys from malaria infection by immunization with recombinant hybrid proteins. Infect Immun. 1992 Jun;60(6):2397–2401. doi: 10.1128/iai.60.6.2397-2401.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Knapp B., Hundt E., Nau U., Küpper H. A. Molecular cloning, genomic structure and localization in a blood stage antigen of Plasmodium falciparum characterized by a serine stretch. Mol Biochem Parasitol. 1989 Jan 1;32(1):73–83. doi: 10.1016/0166-6851(89)90131-x. [DOI] [PubMed] [Google Scholar]
  24. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  25. Lew A. M., Langford C. J., Pye D., Edwards S., Corcoran L., Anders R. F. Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia. J Immunol. 1989 Jun 1;142(11):4012–4016. [PubMed] [Google Scholar]
  26. Li W. B., Bzik D. J., Horii T., Inselburg J. Structure and expression of the Plasmodium falciparum SERA gene. Mol Biochem Parasitol. 1989 Feb;33(1):13–25. doi: 10.1016/0166-6851(89)90037-6. [DOI] [PubMed] [Google Scholar]
  27. Morrissey J. H. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981 Nov 1;117(2):307–310. doi: 10.1016/0003-2697(81)90783-1. [DOI] [PubMed] [Google Scholar]
  28. Patarroyo M. E., Vinasco J., Amador R., Espejo F., Silva Y., Moreno A., Rojas M., Mora A. L., Salcedo M., Valero V. Genetic control of the immune response to a synthetic vaccine against Plasmodium falciparum. Parasite Immunol. 1991 Sep;13(5):509–516. doi: 10.1111/j.1365-3024.1991.tb00547.x. [DOI] [PubMed] [Google Scholar]
  29. Pavia C. S., Diggs C. L., Williams J. The use of metrizamide for isopyknic separation and enrichment of Plasmodium falciparum schizonts from continuous culture. Am J Trop Med Hyg. 1983 Jul;32(4):675–681. doi: 10.4269/ajtmh.1983.32.675. [DOI] [PubMed] [Google Scholar]
  30. Perrin L. H., Loche M., Dedet J. P., Roussilhon C., Fandeur T. Immunization against Plasmodium falciparum asexual blood stages using soluble antigens. Clin Exp Immunol. 1984 Apr;56(1):67–72. [PMC free article] [PubMed] [Google Scholar]
  31. Riley E. M., Ong C. S., Olerup O., Eida S., Allen S. J., Bennett S., Andersson G., Targett G. A. Cellular and humoral immune responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals. Limited response to the 48/45-kilodalton surface antigen does not appear to be due to MHC restriction. J Immunol. 1990 Jun 15;144(12):4810–4816. [PubMed] [Google Scholar]
  32. Roussilhon C., Hundt E., Agrapart M., Stüber W., Knapp B., Dubois P., Ballet J. J. Responses of T cells from sensitized donors to recombinant and synthetic peptides corresponding to sequences of the Plasmodium falciparum SERP antigen. Immunol Lett. 1990 Aug;25(1-3):149–153. doi: 10.1016/0165-2478(90)90107-2. [DOI] [PubMed] [Google Scholar]
  33. Roy S., Scherer M. T., Briner T. J., Smith J. A., Gefter M. L. Murine MHC polymorphism and T cell specificities. Science. 1989 May 5;244(4904):572–575. doi: 10.1126/science.2470147. [DOI] [PubMed] [Google Scholar]
  34. Togna A. R., Del Giudice G., Verdini A. S., Bonelli F., Pessi A., Engers H. D., Corradin G. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice. J Immunol. 1986 Nov 1;137(9):2956–2960. [PubMed] [Google Scholar]
  35. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  37. Troye-Blomberg M., Olerup O., Larsson A., Sjöberg K., Perlmann H., Riley E., Lepers J. P., Perlmann P. Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA. Int Immunol. 1991 Oct;3(10):1043–1051. doi: 10.1093/intimm/3.10.1043. [DOI] [PubMed] [Google Scholar]
  38. Vernes A., Haynes J. D., Tapchaisri P., Williams J. L., Dutoit E., Diggs C. L. Plasmodium falciparum strain-specific human antibody inhibits merozoite invasion of erythrocytes. Am J Trop Med Hyg. 1984 Mar;33(2):197–203. doi: 10.4269/ajtmh.1984.33.197. [DOI] [PubMed] [Google Scholar]
  39. Wolowczuk I., Auriault C., Gras-Masse H., Vendeville C., Balloul J. M., Tartar A., Capron A. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen. J Immunol. 1989 Feb 15;142(4):1342–1350. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES